Literature DB >> 12686302

The treatment of pterygium.

Lawrence W Hirst1.   

Abstract

The treatment of pterygium is still quite controversial, with various treatments being advocated in the scientific literature. Unfortunately, there are very few well-conducted controlled clinical trials of treatments. However, years of anecdotal and noncontrolled studies have confirmed that some methods, such as bare scleral closure, are no longer acceptable in the treatment of pterygium and that other methods are likely to be more useful. In the future it will be important to develop a grading system, and surgeons will need to be conservative in the treatment of pterygium until such time as a single treatment provides a lower recurrence rate and complication rate.

Mesh:

Substances:

Year:  2003        PMID: 12686302     DOI: 10.1016/s0039-6257(02)00463-0

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  68 in total

1.  Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up.

Authors:  Angel Nava-Castañeda; Isabel Ulloa-Orozco; Lilia Garnica-Hayashi; Joaquín Hernandez-Orgaz; Maria Carmen Jimenez-Martinez; Yonathan Garfias
Journal:  J Ocul Pharmacol Ther       Date:  2014-11-04       Impact factor: 2.671

2.  Resolution of Corneal Dellen After an Uneventful Pterygium Surgery with Punctal Cautery.

Authors:  Bharti Sharma; Sushil Kumar Bajoria; Abhishek Patnaik; Ravi Barbhaya
Journal:  Cureus       Date:  2020-05-23

3.  Sutureless amniotic membrane transplantation combined with narrow-strip conjunctival autograft for pterygium.

Authors:  Hande Taylan Sekeroglu; Elif Erdem; Nese Cetin Dogan; Meltem Yagmur; Reha Ersoz; Ahmet Dogan
Journal:  Int Ophthalmol       Date:  2011-12-07       Impact factor: 2.031

4.  Comparison of conjunctival autograft transplantation and amniotic membrane transplantation for pterygium: a meta-analysis.

Authors:  Meiyan Li; Min Zhu; Yongfu Yu; Lan Gong; Naiqing Zhao; Mark J Robitaille
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-21       Impact factor: 3.117

5.  [Pterygium. Etiology, clinical aspects and novel adjuvant therapies].

Authors:  L M Heindl; C Cursiefen
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

6.  Proliferative and migratory aptitude in pterygium.

Authors:  Haiqing Bai; Yufei Teng; Lee Wong; Vishal Jhanji; Chi-Pui Pang; Gary Hin-Fai Yam
Journal:  Histochem Cell Biol       Date:  2010-10-12       Impact factor: 4.304

7.  Inverse globe retraction syndrome complicating recurrent pterygium.

Authors:  A O Khan
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

8.  Postoperative subconjunctival 5-fluorouracil in the management of recurring pterygium.

Authors:  Anupama Pherwani; Vipul Vakil; Habibullah Eatamadi; Ravinder Singh; Harminder S Dua
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

9.  Ophthalmic pterygium: a stem cell disorder with premalignant features.

Authors:  Jeanie Chui; Minas T Coroneo; Lien T Tat; Roger Crouch; Denis Wakefield; Nick Di Girolamo
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

10.  [Recurrence rates after pterygium excision with sliding conjunctival flap versus free conjunctival autograft].

Authors:  S Müller; J Stahn; K Schmitz; W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2007-06       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.